104 related articles for article (PubMed ID: 22237045)
1. Work disability rates in RA. Results from an inception cohort with 24 years follow-up.
Nikiphorou E; Guh D; Bansback N; Zhang W; Dixey J; Williams P; Young A
Rheumatology (Oxford); 2012 Feb; 51(2):385-92. PubMed ID: 22237045
[TBL] [Abstract][Full Text] [Related]
2. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
Capell H; McCarey D; Madhok R; Hampson R
J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
[TBL] [Abstract][Full Text] [Related]
3. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
4. Work disability in rheumatoid arthritis 10 years after the diagnosis.
Sokka T; Kautiainen H; Möttönen T; Hannonen P
J Rheumatol; 1999 Aug; 26(8):1681-5. PubMed ID: 10451062
[TBL] [Abstract][Full Text] [Related]
5. Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register.
Odegård S; Finset A; Kvien TK; Mowinckel P; Uhlig T
Scand J Rheumatol; 2005; 34(6):441-7. PubMed ID: 16393765
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.
Bansback N; Zhang W; Walsh D; Kiely P; Williams R; Guh D; Anis A; Young A
Rheumatology (Oxford); 2012 Feb; 51(2):375-84. PubMed ID: 22179728
[TBL] [Abstract][Full Text] [Related]
7. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.
Yelin E; Trupin L; Katz P; Lubeck D; Rush S; Wanke L
Arthritis Rheum; 2003 Nov; 48(11):3046-54. PubMed ID: 14613265
[TBL] [Abstract][Full Text] [Related]
8. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
Gordon P; West J; Jones H; Gibson T
J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
[TBL] [Abstract][Full Text] [Related]
9. Disability in rheumatoid arthritis in the era of biological treatments.
Krishnan E; Lingala B; Bruce B; Fries JF
Ann Rheum Dis; 2012 Feb; 71(2):213-8. PubMed ID: 21953343
[TBL] [Abstract][Full Text] [Related]
10. The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents.
Hallert E; Husberg M; Bernfort L
Rheumatology (Oxford); 2012 Feb; 51(2):338-46. PubMed ID: 22096014
[TBL] [Abstract][Full Text] [Related]
11. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
Welsing PM; Fransen J; van Riel PL
Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
[TBL] [Abstract][Full Text] [Related]
12. Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009.
Kievit W; Fransen J; de Waal Malefijt MC; den Broeder AA; van Riel PL
Rheumatology (Oxford); 2013 Aug; 52(8):1500-8. PubMed ID: 23657913
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
14. The methotrexate therapeutic response in rheumatoid arthritis.
Ortendahl M; Holmes T; Schettler JD; Fries JF
J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
[TBL] [Abstract][Full Text] [Related]
15. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.
Eberhardt K; Larsson BM; Nived K; Lindqvist E
J Rheumatol; 2007 Mar; 34(3):481-7. PubMed ID: 17299844
[TBL] [Abstract][Full Text] [Related]
16. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
17. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).
Young A; Dixey J; Kulinskaya E; Cox N; Davies P; Devlin J; Emery P; Gough A; James D; Prouse P; Williams P; Winfield J
Ann Rheum Dis; 2002 Apr; 61(4):335-40. PubMed ID: 11874837
[TBL] [Abstract][Full Text] [Related]
18. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.
Koduri G; Norton S; Young A; Cox N; Davies P; Devlin J; Dixey J; Gough A; Prouse P; Winfield J; Williams P;
Rheumatology (Oxford); 2010 Aug; 49(8):1483-9. PubMed ID: 20223814
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
